News

Foley Hoag Advises ArkeaBio in $26.5M Series A Funding Round

June 12, 2024

Foley Hoag LLP advised ArkeaBio, an ag-biotech startup developing a vaccine to reduce livestock methane emissions, in closing a $26.5 million Series A financing round led by current investor Breakthrough Energy Ventures.

ArkeaBio will use the funding for research and development related to its vaccine, which will provide an innovative, cost-effective, and scalable solution to reduce the world’s livestock methane emissions, which currently generate the equivalent of 3 Billion Tons of CO2 annually and represent 6% of annual Greenhouse gas emissions.

Foley Hoag attorneys Mark Barnett, Erin Callahan, and Jason Roche advised ArkeaBio in the transaction.